Therapy of moderate-to-severe Graves’ orbitopathy with intravenous methylprednisolone pulses is not associated with loss of bone mineral density
Author:
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Link
http://link.springer.com/content/pdf/10.1007/s12020-018-1823-x.pdf
Reference41 articles.
1. P. Miśkiewicz, A. Kryczka, U. Ambroziak, B. Rutkowska, R. Główczyńska, G. Opolski, G. Kahaly, T. Bednarczuk, Is high dose intravenous methylprednisolone pulse therapy in patients with Graves' orbitopathy safe? Endokrynol. Pol. 65, 402–413 (2014)
2. L. Bartalena, L. Baldeschi, K. Boboridis, A. Eckstein, G.J. Kahaly, C. Marcocci, P. Perros, M. Salvi, W. Wiersinga, The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy. Eur. Thyroid J. 5, 9–26 (2016)
3. H. Stiebel-Kalish, E. Robenshtock, M. Hasanreisoglu, D. Ezrachi, I. Shimon, L. Leibovici, Treatment modalities for Graves' ophthalmopathy: systematic review and metaanalysis. J. Clin. Endocrinol. Metab. 94, 2708–2716 (2009)
4. C. Marcocci, T. Watt, M.A. Altea, A.K. Rasmussen, U. Feldt-Rasmussen, J. Orgiazzi, L. Bartalena; European Group of Graves' Orbitopathy, Fatal and non-fatal adverse events of glucocorticoid therapy for Graves' orbitopathy: a questionnaire survey among members of the European Thyroid Association. Eur. J. Endocrinol. 166, 247–253 (2012)
5. M. Moleti, G. Giuffrida, G. Sturnilo, G. Squadrito, A. Campenni, S. Morelli, E. Puxeddu, E. Sisti, F. Trimarchi, F. Vermiglio, M. Marinò, Acute liver damage following intravenous glucocorticoid treatment for Graves’ ophthalmopathy. Endocrine 54, 256–268 (2016)
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Bone turnover decreases and bone structure improves during treatment with weekly high-dose methylprednisolone for 12 weeks in Graves’ orbitopathy;Endocrine;2023-09-07
2. Bone turnover decreases and bone structure improves during treatment with weekly high-dose methylprednisolone for 12 weeks in Graves’ orbitopathy;2023-06-07
3. Decrease in Bone Formation and Bone Resorption during Intravenous Methylprednisolone Pulse Therapy in Patients with Graves’ Orbitopathy;Journal of Clinical Medicine;2022-08-26
4. Therapy With Intravenous Methylprednisolone Pulses Is Associated With Loss of Bone Microarchitecture in Trabecular Bone Score -Assessment Among Patients With Moderate-to-Severe Graves’ Orbitopathy: A Pilot Study;Frontiers in Endocrinology;2022-07-14
5. Focus on radioiodine-131 biokinetics: the influence of methylprednisolone on intratherapeutic effective half-life of 131I during radioiodine therapy of Graves’ disease;Endocrine;2021-01-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3